Key result
Planned study hypothesizes depression is linked to higher polypharmacy risk in geriatric diabetic patients.
Why the study?
Polypharmacy is common in diabetes and has been linked to depression, serving as a consistent predictor of inappropriate medication in the elderly. The study aimed to assess the correlation between polypharmacy and accompanying depression in geriatric diabetic patients.
Is there an association between depression and polypharmacy among geriatric diabetic patients?
Cross-Sectional
No
Is there an association between depression and polypharmacy among geriatric diabetic patients?
This study protocol aims to evaluate the association between depression and polypharmacy in elderly diabetic patients to help rationalize drug utilization.
Answers are grounded in this paper and cite their sources.
No results reported; leaves open whether depression increases polypharmacy risk in geriatric diabetic patients.
Background: Diabetes mellitus, one of the common serious conditions among the elderly and depression is frequent finding as a Comorbidity. Polypharmacy is common in diabetes and In diabetic senior people, it has been linked to depression. Polypharmacy, especially among the elderly, is a consistent predictor of inappropriate medication. Approaching and analysing the prescription pattern in elderly diabetic patient will rationalize the drug utilization. The current research is to access the co-relation of polypharmacy in geriatric diabetic patient and accompanying depression. Objectives: To assess depression and polypharmacy and correlate their association in diabetic patients of geriatric age group. Methodology: This is questionnaire based cross sectional observational study. This shall be conducted in geriatric population attending Medicine department [OPD and IPD] [AVBRH], DMIMS, Sawangi [M], Wardha, Maharashtra, India. The depression will be assessed using Geriatric Depression scale. The Polypharmacy will be assessed using contingency table and odds ratio. Expected outcome: It is hypothesized that geriatric diabetic patients with depression [GDS>= 6] are at higher risk of encountering polypharmacy. Conclusion: To upgrades standards of life of senior diabetic patients, prescribing procedures should be reviewed.
No takes yet. Share an insight, caveat, or question.
Thakkar et al. (2021) conducted a cross-sectional in Diabetes mellitus. This planned cross-sectional study hypothesizes that geriatric diabetic patients with depression (GDS>=6) are at higher risk of encountering polypharmacy, with no clinical results reported yet.
Synapse has enriched 10 related papers. Consider them for comparative context: